Bilastine

比拉斯汀

Report date: 2026/01/30 10:14:58
NME

Base Information

Drug NameBilastine
Drug Alias NameBorenar吡拉斯汀InorialNasitopRobilas +[41] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsHypersensitivityChronic UrticariaUrticaria +[12] 
Global Approved IndicationsChronic UrticariaUrticariaPruritus +[9] 
Approved Indications in ChinaUrticaria
Original Approved Country/TerritorySpain
Original Approved Date2010/01/01
Country/TerritoryBelgiumCanadaUnited States +[18] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesFaes Farma
China Registration ClassN/A

Develop Information

Active CompaniesHumanis Saglık Anonim SirketiTaiho Pharmaceutical Co LtdHikma Pharmaceuticals +[4] 
Inactive CompaniesFAES Farma SACharite University, Berlin, GermanyA.Menarini Manufacturing Logistics And Services Srl +[7] 
Active IndicationsChronic UrticariaUrticariaPruritus +[9] 
Inactive IndicationsHypersensitivityConjunctivitisRhinitis

Other Information

ATC CodeR06AX29
Related LinksWikipediaDrugBankKEGG